Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01835964 · ClinicalTrials.gov registry record · NA
Biobehavioral Mechanisms of Glucose Variability
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01835964 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 30 participants.
The verdict
NCT01835964, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate how blood sugar changes in response to insulin and what the body does to counter-act low blood sugar in people with Type 1 Diabetes Mellitus. Insulin sensitivity is the term used to describe blood sugar changes within the body in response to insulin. Greater understanding of insulin sensitivity, particularly how the body responds to low blood sugar, will help us to better predict how blood sugar levels will change. All subjects will receive a liquid mixed-meal and will have their blood sugar response monitored in order to study insulin sensitivity. All subjects will receive additional insulin injections that are given to cause a low blood sugar in order to understand how the body responds to a low blood sugar. All subjects will be closely monitored during the time the insulin is given, by frequent checks of blood sugar and constant medical and nursing supervision. Details of the visits, tests and procedures are described below. During this study, the study team will ask that subjects to use their own insulin pump and own glucometer. Subjects will need to use the same glucometer for the entire study. Subjects will be provided 1 box of strips. Subjects will be required to use lispro (Humalog) insulin 2-3 days before your inpatient admission which will be provided free of charge.
Interventions
- PROCEDURE Glucose Variability Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01835964
The ClinicalTrials.gov registry entry for NCT01835964 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Glucose Variability Observation is the first listed.
NCT01835964 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01835964 about?
NCT01835964 is a clinical study titled "Biobehavioral Mechanisms of Glucose Variability". The purpose of this study is to investigate how blood sugar changes in response to insulin and what the body does to counter-act low blood sugar in people with Type 1 Diabetes Mellitus. Insulin sensitivity is the term used to describe blood sugar changes within the body in response to insulin. Great...
What is the current status of trial NCT01835964?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-04. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01835964?
The interventions under investigation include: Glucose Variability Observation (PROCEDURE).
Who is sponsoring clinical trial NCT01835964?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.